更多...
This gene encodes an enzyme involved in catalyzing the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This enzyme plays a key role in the renin-angiotensin system. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme or cardiovascular pathophysiologies. Multiple alternatively spliced transcript variants encoding different isoforms have been identified, and two most abundant spliced variants encode the somatic form and the testicular form, respectively, that are equally active. [provided by RefSeq, May 2010]
[中文简述(自动翻译):] 该基??因编码参与催化血管紧张素I转化成生理活性肽血管紧张素II的酶。血管紧张素II是有效的血管加压和醛固酮刺激肽,控制血压和流体电解质平衡。这种酶起了肾素 - 血管紧张素系统的关键作用。许多研究都与循环酶或心血管病理生理学的水平有关在这个基因的287 bp的Alu重复元素的存在或不存在。多个可变剪接转录物变体编码不同同种型已被识别,并且两个最丰富剪接变体编码的躯体形式和睾丸的形式,分别是同样有效。 [由RefSeq的,2010年5月提供]
ACE基因(以及对应的蛋白质)的细胞分布位置:
ACE基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Myocardial Infarction | 0.461938404 | 213 | 3 | BeFree_CLINVAR_CTD_human_GAD_LHGDN_RGD |
Hypertensive disease | 0.44 | 508 | 13 | BeFree_CTD_human_GAD_LHGDN_RGD |
Allanson Pantzar McLeod syndrome | 0.360814326 | 4 | 5 | BeFree_CLINVAR_CTD_human_ORPHANET |
Diabetic Nephropathy | 0.332098819 | 146 | 4 | BeFree_CTD_human_GAD_LHGDN_RGD |
Left Ventricular Hypertrophy | 0.317790009 | 108 | 0 | BeFree_CTD_human_GAD_LHGDN_RGD |
Alzheimer's Disease | 0.307766523 | 58 | 0 | BeFree_CTD_human_GAD_LHGDN_RGD |
Cerebrovascular accident | 0.30011871 | 82 | 2 | BeFree_CTD_human_GAD_LHGDN_RGD |
Heart failure | 0.276795777 | 86 | 2 | BeFree_CTD_human_GAD_LHGDN_RGD |
Coronary Artery Disease | 0.265255296 | 145 | 9 | BeFree_CTD_human_GAD_LHGDN |
Cardiovascular Diseases | 0.260603275 | 193 | 6 | BeFree_CTD_human_GAD_LHGDN |
Coronary heart disease | 0.245612166 | 179 | 6 | BeFree_CTD_human_GAD_LHGDN |
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3 (finding) | 0.24 | 0 | 1 | CLINVAR_CTD_human |
Kidney Failure, Chronic | 0.224449632 | 97 | 2 | BeFree_CTD_human_GAD_LHGDN |
Lung diseases | 0.207915422 | 8 | 0 | BeFree_CTD_human_GAD_RGD |
Kidney Diseases | 0.203095022 | 141 | 4 | BeFree_CTD_human_GAD |
Diabetes Mellitus, Experimental | 0.2 | 2 | 0 | CTD_human_RGD |
IGA Glomerulonephritis | 0.176817361 | 45 | 1 | BeFree_CTD_human_GAD_LHGDN |
Pre-Eclampsia | 0.166402881 | 17 | 0 | CTD_human_GAD_LHGDN |
Brain Ischemia | 0.164973608 | 20 | 0 | CTD_human_GAD |
Atrial Fibrillation | 0.151843371 | 12 | 0 | CTD_human_GAD_LHGDN |
Albuminuria | 0.144027638 | 11 | 0 | CTD_human_GAD_LHGDN |
Coronary Restenosis | 0.142931939 | 15 | 0 | BeFree_CTD_human_GAD |
Obesity | 0.139208137 | 47 | 4 | BeFree_GAD_RGD |
Pulmonary Hypertension | 0.136078541 | 15 | 0 | BeFree_CTD_human_GAD_LHGDN |
Stomach Neoplasms | 0.13518827 | 6 | 0 | BeFree_CTD_human_GAD_LHGDN |
Coughing | 0.135168407 | 25 | 1 | BeFree_CTD_human_GAD |
Glycogen Storage Disease Type V | 0.133364122 | 5 | 1 | BeFree_CTD_human_GAD_LHGDN |
Diabetes Mellitus, Non-Insulin-Dependent | 0.127823427 | 171 | 3 | BeFree_GAD_LHGDN |
Lung Neoplasms | 0.127458414 | 4 | 0 | CTD_human_GAD_LHGDN |
Cerebral Hemorrhage | 0.127458414 | 3 | 0 | CTD_human_GAD_LHGDN |
Renal Insufficiency | 0.126362715 | 9 | 1 | BeFree_CTD_human_GAD |
Severe Acute Respiratory Syndrome | 0.125276948 | 3 | 0 | BeFree_CTD_human_GAD |
Cardiac Arrhythmia | 0.125091382 | 3 | 0 | CTD_human_GAD_LHGDN |
Prostatic Neoplasms | 0.125091382 | 2 | 0 | CTD_human_GAD_LHGDN |
Infant, Premature, Diseases | 0.124734064 | 2 | 0 | CTD_human_GAD |
Liver carcinoma | 0.124624443 | 9 | 0 | BeFree_CTD_human_LHGDN |
Meningococcal Infections | 0.122909916 | 2 | 0 | BeFree_CTD_human_GAD |
Drug Allergy | 0.122638474 | 2 | 0 | BeFree_CTD_human_GAD |
Adenocarcinoma | 0.122367032 | 2 | 0 | CTD_human_GAD |
Gaucher Disease | 0.122367032 | 1 | 0 | CTD_human_GAD |
Pneumonia, Viral | 0.122367032 | 1 | 0 | CTD_human_GAD |
Respiratory Tract Diseases | 0.122367032 | 1 | 0 | CTD_human_GAD |
Male infertility | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Neoplasm Metastasis | 0.120542884 | 2 | 0 | BeFree_CTD_human |
Berylliosis | 0.12 | 1 | 0 | CTD_human |
Sudden death | 0.12 | 1 | 0 | CTD_human |
Hypotension | 0.12 | 1 | 0 | CTD_human |
Psychoses, Substance-Induced | 0.12 | 1 | 0 | CTD_human |
Staphylococcal Infections | 0.12 | 1 | 0 | CTD_human |
Non-alcoholic Fatty Liver Disease | 0.12 | 1 | 0 | CTD_human |
ANGIOTENSIN I-CONVERTING ENZYME, BENIGN SERUM INCREASE | 0.12 | 0 | 1 | CLINVAR |
IgA NEPHROPATHY, PROGRESSION TO RENAL FAILURE IN, SUSCEPTIBILITY TO | 0.12 | 0 | 1 | CLINVAR |
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1(finding) | 0.12 | 0 | 0 | CTD_human |
Pregnancy associated hypertension | 0.09455951 | 7 | 0 | GAD_LHGDN_RGD |
Bipolar Disorder | 0.090553895 | 8 | 0 | BeFree_GAD_RGD |
Liver Cirrhosis | 0.08764398 | 6 | 0 | BeFree_GAD_RGD |
Glomerulonephritis | 0.083452799 | 6 | 0 | BeFree_GAD_RGD |
Pulmonary Fibrosis | 0.083181358 | 6 | 0 | BeFree_GAD_RGD |
Reperfusion Injury | 0.082367032 | 2 | 0 | GAD_RGD |
Hypertension, Renovascular | 0.080542884 | 4 | 1 | BeFree_RGD |
Right Ventricular Hypertrophy | 0.080542884 | 3 | 0 | BeFree_RGD |
Osteoporosis | 0.080271442 | 2 | 0 | BeFree_RGD |
Bronchiolitis Obliterans | 0.08 | 1 | 0 | RGD |
Biliary cirrhosis | 0.08 | 1 | 0 | RGD |
Memory Disorders | 0.08 | 1 | 0 | RGD |
Nephrosis | 0.08 | 1 | 0 | RGD |
Pain | 0.08 | 1 | 0 | RGD |
Autosomal Recessive Polycystic Kidney Disease | 0.08 | 1 | 0 | RGD |
Endotoxemia | 0.08 | 1 | 0 | RGD |
Endomyocardial Fibrosis | 0.08 | 1 | 0 | RGD |
Ventricular Remodeling | 0.08 | 1 | 0 | RGD |
Diabetic Cardiomyopathies | 0.08 | 1 | 0 | RGD |
Arthritis, Experimental | 0.08 | 1 | 0 | RGD |
Acute kidney injury | 0.08 | 1 | 0 | RGD |
Coronary Arteriosclerosis | 0.071759138 | 160 | 3 | BeFree_GAD |
Diabetes Mellitus, Insulin-Dependent | 0.066189681 | 60 | 0 | BeFree_GAD |
Atherosclerosis | 0.055907227 | 61 | 0 | BeFree_GAD |
Lupus Erythematosus, Systemic | 0.051931407 | 27 | 0 | BeFree_GAD_LHGDN |
Chronic Obstructive Airway Disease | 0.043658667 | 26 | 0 | BeFree_GAD_LHGDN |
Sarcoidosis | 0.042972487 | 42 | 0 | BeFree_GAD_LHGDN |
Asthma | 0.041291635 | 25 | 0 | BeFree_GAD_LHGDN |
Metabolic Syndrome X | 0.037100455 | 29 | 3 | BeFree_GAD_LHGDN |
Myocardial Ischemia | 0.035733314 | 38 | 0 | BeFree_GAD |
Diabetes Mellitus | 0.033821952 | 85 | 2 | BeFree_GAD |
Nephrotic Syndrome | 0.033557898 | 15 | 0 | BeFree_GAD_LHGDN |
Essential Hypertension | 0.033235461 | 106 | 3 | BeFree_GAD |
Insulin Resistance | 0.030771416 | 13 | 0 | GAD |
Vesico-Ureteral Reflux | 0.029837538 | 17 | 0 | BeFree_GAD |
Systemic arterial pressure | 0.028404384 | 12 | 0 | GAD |
Migraine Disorders | 0.026003676 | 17 | 1 | BeFree_GAD_LHGDN |
Kidney Failure | 0.025135812 | 53 | 2 | BeFree_GAD |
Diabetic Retinopathy | 0.024832032 | 19 | 0 | BeFree_GAD |
Aortic Aneurysm, Abdominal | 0.024375025 | 13 | 0 | BeFree_GAD_LHGDN |
Hypertrophic Cardiomyopathy | 0.024265404 | 20 | 0 | BeFree_GAD_LHGDN |
Focal glomerulosclerosis | 0.024189459 | 11 | 0 | BeFree_GAD_LHGDN |
Congestive heart failure | 0.023886885 | 88 | 2 | BeFree |
Altitude Sickness | 0.02367032 | 10 | 0 | GAD |
Proteinuria | 0.02367032 | 10 | 0 | GAD |
Proteinuria Adverse Event | 0.02367032 | 10 | 0 | GAD |
Malignant neoplasm of breast | 0.023550768 | 17 | 0 | BeFree_GAD |
Schizophrenia | 0.022365311 | 11 | 0 | BeFree_GAD_LHGDN |
Respiratory Distress Syndrome, Adult | 0.022083938 | 19 | 0 | BeFree_GAD_LHGDN |
Coronary Stenosis | 0.022007993 | 16 | 0 | BeFree_GAD_LHGDN |
Cardiomyopathies | 0.021888441 | 31 | 0 | BeFree_GAD_LHGDN |
Vascular Diseases | 0.020445355 | 28 | 0 | BeFree_GAD |
Arteriosclerosis | 0.020130306 | 50 | 0 | BeFree_GAD |
Erectile dysfunction | 0.019640961 | 11 | 2 | BeFree_GAD_LHGDN |
Peripheral Vascular Diseases | 0.019369519 | 12 | 0 | BeFree_GAD_LHGDN |
Venous Thrombosis | 0.019293574 | 7 | 0 | GAD_LHGDN |
Cerebral Infarction | 0.018740759 | 11 | 0 | BeFree_GAD |
Restenosis | 0.018230213 | 43 | 1 | BeFree_GAD |
Psoriasis | 0.017717124 | 9 | 0 | BeFree_GAD_LHGDN |
Diabetes | 0.01737228 | 64 | 2 | BeFree |
Hypoglycemia | 0.017088363 | 9 | 0 | BeFree_GAD_LHGDN |
Systemic Scleroderma | 0.017088363 | 8 | 4 | BeFree_GAD_LHGDN |
Ischemic stroke | 0.016058678 | 33 | 3 | BeFree_GAD |
Pulmonary Edema | 0.014916828 | 5 | 0 | GAD_LHGDN |
Heart Diseases | 0.014354082 | 20 | 0 | BeFree_GAD |
Postoperative Complications | 0.014202192 | 6 | 0 | GAD |
Thrombosis | 0.014202192 | 6 | 0 | GAD |
Premature Birth | 0.014202192 | 6 | 0 | GAD |
Ventricular Dysfunction, Left | 0.014202192 | 6 | 0 | GAD |
Dementia | 0.01408264 | 18 | 0 | BeFree_GAD |
Endometriosis | 0.013907006 | 5 | 0 | BeFree_GAD_LHGDN |
Polycystic Kidney, Autosomal Dominant | 0.013897074 | 16 | 1 | BeFree_GAD_LHGDN |
Mucocutaneous Lymph Node Syndrome | 0.013635564 | 4 | 0 | BeFree_GAD_LHGDN |
Behcet Syndrome | 0.013549688 | 6 | 0 | BeFree_GAD_LHGDN |
Lupus Erythematosus | 0.013463811 | 10 | 0 | BeFree_GAD |
Sleep Apnea, Obstructive | 0.013354191 | 15 | 0 | BeFree_GAD_LHGDN |
Mental Depression | 0.013268314 | 18 | 9 | BeFree_GAD |
Inflammatory Bowel Diseases | 0.013006804 | 5 | 1 | BeFree_GAD_LHGDN |
Thrombophilia | 0.012920927 | 9 | 1 | BeFree_GAD |
Lupus Nephritis | 0.012811307 | 13 | 0 | BeFree_GAD_LHGDN |
Venous Thromboembolism | 0.012549796 | 4 | 0 | GAD_LHGDN |
Carotid Artery Diseases | 0.012106602 | 6 | 0 | BeFree_GAD |
Polycystic Kidney Diseases | 0.012106602 | 5 | 0 | BeFree_GAD |
Calcinosis | 0.01183516 | 5 | 0 | GAD |
Cerebrovascular Disorders | 0.01183516 | 5 | 0 | GAD |
Cicatrization | 0.01183516 | 5 | 0 | GAD |
Weight Gain | 0.01183516 | 5 | 0 | GAD |
Weight Gain Adverse Event | 0.01183516 | 5 | 0 | GAD |
Dementia, Vascular | 0.011454097 | 8 | 0 | BeFree_GAD_LHGDN |
Polycystic Ovary Syndrome | 0.011368221 | 7 | 0 | BeFree_GAD |
Malignant neoplasm of prostate | 0.011368221 | 8 | 0 | BeFree_GAD |
Aortic Valve Stenosis | 0.011182656 | 7 | 0 | BeFree_GAD_LHGDN |
Migraine with Aura | 0.011182656 | 6 | 0 | BeFree_GAD_LHGDN |
Retinal Diseases | 0.011172724 | 18 | 0 | BeFree_GAD |
Lupus Vulgaris | 0.011096779 | 9 | 0 | BeFree_GAD |
Lupus Erythematosus, Discoid | 0.011096779 | 9 | 0 | BeFree_GAD |
Rheumatic Heart Disease | 0.011096779 | 8 | 0 | BeFree_GAD |
Age related macular degeneration | 0.010911214 | 5 | 0 | BeFree_GAD_LHGDN |
Overweight | 0.010825337 | 7 | 0 | BeFree_GAD |
Colorectal Cancer | 0.010825337 | 7 | 0 | BeFree_GAD |
Chronic kidney disease stage 5 | 0.010586233 | 39 | 1 | BeFree |
Sepsis | 0.010553895 | 6 | 0 | BeFree_GAD |
Hyperlipidemia | 0.010282454 | 7 | 0 | BeFree_GAD |
Urinary tract infection | 0.010282454 | 5 | 0 | BeFree_GAD |
Fibrosis | 0.010182764 | 4 | 0 | GAD_LHGDN |
Glaucoma, Open-Angle | 0.010182764 | 2 | 0 | GAD_LHGDN |
Parkinson Disease | 0.009825446 | 3 | 0 | GAD_LHGDN |
Leukoaraiosis | 0.009825446 | 4 | 0 | GAD_LHGDN |
Diabetic Angiopathies | 0.00973957 | 5 | 0 | BeFree_GAD |
Hypercholesterolemia | 0.00973957 | 5 | 1 | BeFree_GAD |
Renal hypertension | 0.00973957 | 5 | 1 | BeFree_GAD |
Pneumonia | 0.009544073 | 9 | 1 | BeFree_GAD |
Anoxia | 0.009468128 | 4 | 0 | GAD |
Sudden Cardiac Death | 0.009468128 | 4 | 0 | GAD |
Complications of Diabetes Mellitus | 0.009468128 | 4 | 0 | GAD |
Bronchopulmonary Dysplasia | 0.009358507 | 7 | 2 | BeFree_GAD_LHGDN |
Polycythemia | 0.009001189 | 7 | 0 | BeFree_GAD |
Thromboembolism | 0.009001189 | 7 | 0 | BeFree_GAD |
Vitiligo | 0.008729747 | 7 | 0 | BeFree_GAD |
Arthritis, Psoriatic | 0.00827274 | 3 | 0 | BeFree_GAD_LHGDN |
Hyperhomocysteinemia | 0.00827274 | 3 | 0 | BeFree_GAD_LHGDN |
Kidney Failure, Acute | 0.008186863 | 4 | 0 | BeFree_GAD |
Subarachnoid Hemorrhage | 0.008186863 | 6 | 0 | BeFree_GAD |
Alcoholic Intoxication, Chronic | 0.007915422 | 6 | 0 | BeFree_GAD |
Cardiomegaly | 0.007815732 | 3 | 0 | GAD_LHGDN |
Hepatitis C | 0.007729856 | 2 | 0 | BeFree_GAD_LHGDN |
Impaired cognition | 0.007719925 | 12 | 1 | BeFree_GAD |
Squamous cell carcinoma | 0.00764398 | 5 | 0 | BeFree_GAD |
Pulmonary Embolism | 0.00764398 | 3 | 0 | BeFree_GAD |
Sarcoidosis, Pulmonary | 0.00764398 | 4 | 0 | BeFree_GAD |
Connective Tissue Diseases | 0.007458414 | 3 | 0 | GAD_LHGDN |
Chronic Fatigue Syndrome | 0.007458414 | 2 | 0 | GAD_LHGDN |
Heart valve disease | 0.007372538 | 4 | 0 | BeFree_GAD |
Pregnancy Complications | 0.007372538 | 4 | 0 | BeFree_GAD |
Vasovagal syncope | 0.007372538 | 3 | 0 | BeFree_GAD |
Cardiomyopathy, Dilated | 0.007262917 | 8 | 0 | BeFree_GAD_LHGDN |
Nephritis | 0.007177041 | 10 | 0 | BeFree_GAD |
Dyslipidemias | 0.007177041 | 10 | 0 | BeFree_GAD |
Abortion, Habitual | 0.007101096 | 3 | 0 | GAD |
Arterial Occlusive Diseases | 0.007101096 | 3 | 0 | GAD |
Chromosome Deletion | 0.007101096 | 3 | 0 | GAD |
Diabetic Neuropathies | 0.007101096 | 3 | 0 | GAD |
Pathological Dilatation | 0.007101096 | 3 | 0 | GAD |
Fetal Growth Retardation | 0.007101096 | 3 | 0 | GAD |
Inflammation | 0.007101096 | 3 | 0 | GAD |
Long QT Syndrome | 0.007101096 | 3 | 0 | GAD |
Mouth Neoplasms | 0.007101096 | 3 | 0 | GAD |
Pregnancy Complications, Hematologic | 0.007101096 | 3 | 0 | GAD |
Tobacco Use Disorder | 0.007101096 | 3 | 0 | GAD |
Weight Loss Adverse Event | 0.007101096 | 3 | 0 | GAD |
Acute myocardial infarction | 0.006786047 | 25 | 0 | BeFree |
Malignant neoplasm of lung | 0.006634157 | 8 | 0 | BeFree_GAD |
Microalbuminuria | 0.006514605 | 24 | 2 | BeFree |
Depressive disorder | 0.00643866 | 15 | 9 | BeFree_GAD |
Intracranial Aneurysm | 0.006362715 | 7 | 0 | BeFree_GAD |
Chronic Kidney Insufficiency | 0.006362715 | 8 | 0 | BeFree_GAD |
Ischemic Cerebrovascular Accident | 0.006243163 | 23 | 1 | BeFree |
Henoch-Schoenlein Purpura | 0.006091273 | 6 | 0 | BeFree_GAD |
Heart Failure, Systolic | 0.006091273 | 5 | 0 | BeFree_GAD |
Urticaria | 0.005905708 | 3 | 0 | BeFree_GAD_LHGDN |
Respiratory Distress Syndrome, Newborn | 0.005819831 | 6 | 0 | BeFree_GAD |
Fibroid Tumor | 0.005634266 | 2 | 0 | BeFree_GAD_LHGDN |
Mitral Valve Prolapse Syndrome | 0.005634266 | 2 | 0 | BeFree_GAD_LHGDN |
Retinopathy of Prematurity | 0.005634266 | 2 | 0 | BeFree_GAD_LHGDN |
Ankylosing spondylitis | 0.005634266 | 2 | 0 | BeFree_GAD_LHGDN |
Mammary Neoplasms | 0.005634266 | 4 | 0 | BeFree_GAD_LHGDN |
Crohn Disease | 0.00554839 | 3 | 0 | BeFree_GAD |
Sleep Apnea Syndromes | 0.00554839 | 4 | 0 | BeFree_GAD |
Obesity, Abdominal | 0.00554839 | 5 | 0 | BeFree_GAD |
Brain Infarction | 0.00554839 | 4 | 0 | BeFree_GAD |
Cardiomyopathy, Hypertrophic, Familial | 0.00554839 | 5 | 0 | BeFree_GAD |
Heart Failure, Diastolic | 0.00554839 | 3 | 0 | BeFree_GAD |
Endothelial dysfunction | 0.005428837 | 20 | 3 | BeFree |
Esophageal Neoplasms | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
Fatigue | 0.005362824 | 2 | 0 | BeFree_GAD_LHGDN |
Spondylarthropathies | 0.005362824 | 1 | 0 | BeFree_GAD_LHGDN |
Chronic heart failure | 0.005352893 | 11 | 0 | BeFree_GAD |
Aortic Valve Insufficiency | 0.005276948 | 3 | 0 | BeFree_GAD |
Cystic Fibrosis | 0.005276948 | 4 | 0 | BeFree_GAD |
Liver diseases | 0.005276948 | 4 | 0 | BeFree_GAD |
Microvascular Angina | 0.005276948 | 4 | 0 | BeFree_GAD |
Osteoarthritis, Knee | 0.005276948 | 2 | 0 | BeFree_GAD |
Spontaneous abortion | 0.005091382 | 2 | 0 | GAD_LHGDN |
Colorectal Neoplasms | 0.005091382 | 2 | 0 | GAD_LHGDN |
Hypotension, Orthostatic | 0.005091382 | 2 | 0 | GAD_LHGDN |
leukemia | 0.005091382 | 2 | 0 | GAD_LHGDN |
Malignant neoplasm of stomach | 0.005081451 | 10 | 0 | BeFree_GAD |
Anemia, Sickle Cell | 0.005005506 | 3 | 0 | BeFree_GAD |
Dermatologic disorders | 0.005005506 | 3 | 0 | BeFree_GAD |
Aneurysm, Ruptured | 0.005005506 | 2 | 0 | BeFree_GAD |
Carotid Atherosclerosis | 0.004810009 | 9 | 0 | BeFree_GAD |
Angina Pectoris | 0.004734064 | 2 | 0 | GAD |
Angioedema | 0.004734064 | 2 | 0 | GAD |
Arthritis | 0.004734064 | 2 | 0 | GAD |
Intracranial Arteriosclerosis | 0.004734064 | 2 | 0 | GAD |
DNA Damage | 0.004734064 | 2 | 0 | GAD |
Fetal Membranes, Premature Rupture | 0.004734064 | 2 | 0 | GAD |
Graft Occlusion, Vascular | 0.004734064 | 2 | 0 | GAD |
Premature Obstetric Labor | 0.004734064 | 2 | 0 | GAD |
Myotonic Dystrophy | 0.004734064 | 2 | 0 | GAD |
Lipoid nephrosis | 0.004734064 | 2 | 0 | GAD |
Periodontitis | 0.004734064 | 2 | 0 | GAD |
Pregnancy Complications, Cardiovascular | 0.004734064 | 2 | 0 | GAD |
Shock | 0.004734064 | 2 | 0 | GAD |
Blood pressure finding | 0.004734064 | 2 | 0 | GAD |
SARCOIDOSIS, SUSCEPTIBILITY TO, 1 (finding) | 0.004734064 | 2 | 0 | GAD |
Presenile dementia | 0.004614512 | 17 | 0 | BeFree |
Factor V Leiden mutation | 0.004538567 | 9 | 2 | BeFree_GAD |
Breast Carcinoma | 0.00434307 | 16 | 0 | BeFree |
Hyperglycemia | 0.004267125 | 7 | 1 | BeFree_GAD |
Proliferative diabetic retinopathy | 0.004267125 | 7 | 0 | BeFree_GAD |
Acute Coronary Syndrome | 0.004267125 | 8 | 0 | BeFree_GAD |
Rheumatoid Arthritis | 0.003995683 | 6 | 0 | BeFree_GAD |
Mood Disorders | 0.003995683 | 6 | 0 | BeFree_GAD |
Seizures | 0.003724241 | 6 | 0 | BeFree_GAD |
Allergic rhinitis (disorder) | 0.003724241 | 5 | 0 | BeFree_GAD |
Impaired glucose tolerance | 0.003538676 | 4 | 0 | BeFree_LHGDN |
Unipolar Depression | 0.003528744 | 13 | 9 | BeFree |
Angina, Unstable | 0.003452799 | 5 | 0 | BeFree_GAD |
Carotid Stenosis | 0.003452799 | 5 | 0 | BeFree_GAD |
Hypercholesterolemia, Familial | 0.003452799 | 5 | 0 | BeFree_GAD |
Ischemia | 0.003452799 | 5 | 0 | BeFree_GAD |
Multiple Sclerosis | 0.003452799 | 4 | 0 | BeFree_GAD |
Non-obstructive reflux-associated chronic pyelonephritis (disorder) | 0.003452799 | 4 | 0 | BeFree_GAD |
Reflux nephropathy (disorder) | 0.003452799 | 4 | 0 | BeFree_GAD |
Tachycardia | 0.003267234 | 2 | 0 | BeFree_LHGDN |
Old myocardial infarction | 0.003257302 | 12 | 0 | BeFree |
Major Depressive Disorder | 0.003257302 | 12 | 10 | BeFree |
Nephrotic Syndrome, Minimal Change | 0.003257302 | 12 | 0 | BeFree |
Congenital Abnormality | 0.003181358 | 4 | 0 | BeFree_GAD |
Hypertension, Portal | 0.003181358 | 4 | 1 | BeFree_GAD |
Back Pain | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Leukemia, Myelocytic, Acute | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Peripheral Neuropathy | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Subacute Sclerosing Panencephalitis | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Tuberculosis | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Water Intoxication | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Dermatitis, Allergic Contact | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Chronic Kidney Diseases | 0.002985861 | 11 | 1 | BeFree |
Anemia | 0.002909916 | 3 | 0 | BeFree_GAD |
Non-Small Cell Lung Carcinoma | 0.002909916 | 3 | 0 | BeFree_GAD |
Transient Ischemic Attack | 0.002909916 | 3 | 0 | BeFree_GAD |
Renal Artery Stenosis | 0.002909916 | 3 | 0 | BeFree_GAD |
Polydipsia | 0.002909916 | 3 | 0 | BeFree_GAD |
Panic Attacks | 0.002909916 | 3 | 1 | BeFree_GAD |
Memory impairment | 0.002909916 | 3 | 0 | BeFree_GAD |
Congenital posterior urethral valves | 0.002909916 | 3 | 0 | BeFree_GAD |
Chronic Periodontitis | 0.002909916 | 2 | 0 | BeFree_GAD |
Age-associated memory impairment | 0.002909916 | 2 | 0 | BeFree_GAD |
Arteriopathic disease | 0.002909916 | 3 | 0 | BeFree_GAD |
Diaphragmatic Hernia | 0.00272435 | 1 | 0 | LHGDN |
Hypertriglyceridemia | 0.00272435 | 1 | 0 | LHGDN |
Disease Progression | 0.00272435 | 1 | 0 | LHGDN |
Fibrillation | 0.002714419 | 10 | 0 | BeFree |
Stomach Carcinoma | 0.002714419 | 10 | 0 | BeFree |
Cardiomyopathy, Familial Idiopathic | 0.002714419 | 10 | 0 | BeFree |
Cachexia | 0.002638474 | 2 | 0 | BeFree_GAD |
Cerebral Atherosclerosis | 0.002638474 | 1 | 0 | BeFree_GAD |
Ulcerative Colitis | 0.002638474 | 1 | 0 | BeFree_GAD |
Coronary Thrombosis | 0.002638474 | 2 | 0 | BeFree_GAD |
Cushing Syndrome | 0.002638474 | 1 | 0 | BeFree_GAD |
Esophageal Varices | 0.002638474 | 1 | 0 | BeFree_GAD |
Fibromuscular Dysplasia | 0.002638474 | 1 | 0 | BeFree_GAD |
Gastritis, Atrophic | 0.002638474 | 1 | 0 | BeFree_GAD |
Glycogen storage disease type II | 0.002638474 | 1 | 0 | BeFree_GAD |
Congenital Heart Defects | 0.002638474 | 2 | 0 | BeFree_GAD |
HIV Infections | 0.002638474 | 2 | 0 | BeFree_GAD |
Lymphoma | 0.002638474 | 2 | 0 | BeFree_GAD |
Malaria, Cerebral | 0.002638474 | 1 | 0 | BeFree_GAD |
Musculoskeletal Diseases | 0.002638474 | 2 | 0 | BeFree_GAD |
Pancreatitis | 0.002638474 | 1 | 0 | BeFree_GAD |
Peptic Ulcer | 0.002638474 | 1 | 0 | BeFree_GAD |
Raynaud Disease | 0.002638474 | 2 | 0 | BeFree_GAD |
Retinal Artery Occlusion | 0.002638474 | 1 | 0 | BeFree_GAD |
Rheumatic Fever | 0.002638474 | 2 | 0 | BeFree_GAD |
Substance Withdrawal Syndrome | 0.002638474 | 2 | 0 | BeFree_GAD |
Syncope | 0.002638474 | 1 | 0 | BeFree_GAD |
Tuberculosis, Pulmonary | 0.002638474 | 2 | 0 | BeFree_GAD |
Uremia | 0.002638474 | 2 | 0 | BeFree_GAD |
Bronchial Hyperreactivity | 0.002638474 | 2 | 0 | BeFree_GAD |
Gestational Diabetes | 0.002638474 | 2 | 0 | BeFree_GAD |
Chronic glomerulonephritis | 0.002638474 | 2 | 3 | BeFree_GAD |
Hyperandrogenism | 0.002638474 | 1 | 0 | BeFree_GAD |
Cholestasis of pregnancy | 0.002638474 | 1 | 0 | BeFree_GAD |
Arrhythmogenic Right Ventricular Dysplasia | 0.002638474 | 1 | 0 | BeFree_GAD |
Hepatitis C, Chronic | 0.002638474 | 2 | 0 | BeFree_GAD |
Malignant neoplasm of esophagus | 0.002638474 | 1 | 0 | BeFree_GAD |
MAJOR AFFECTIVE DISORDER 2 | 0.002638474 | 1 | 0 | BeFree_GAD |
MAJOR AFFECTIVE DISORDER 1 | 0.002638474 | 1 | 0 | BeFree_GAD |
MAJOR AFFECTIVE DISORDER 4 | 0.002638474 | 1 | 0 | BeFree_GAD |
MAJOR AFFECTIVE DISORDER 5 | 0.002638474 | 1 | 0 | BeFree_GAD |
MAJOR AFFECTIVE DISORDER 6 | 0.002638474 | 1 | 0 | BeFree_GAD |
MAJOR AFFECTIVE DISORDER 7 | 0.002638474 | 1 | 0 | BeFree_GAD |
MAJOR AFFECTIVE DISORDER 8 | 0.002638474 | 1 | 0 | BeFree_GAD |
MAJOR AFFECTIVE DISORDER 9 | 0.002638474 | 1 | 0 | BeFree_GAD |
Juvenile arthritis | 0.002638474 | 1 | 0 | BeFree_GAD |
Aortic Aneurysm | 0.002442977 | 9 | 0 | BeFree |
Eclampsia | 0.002442977 | 9 | 0 | BeFree |
Acidosis | 0.002367032 | 1 | 0 | GAD |
Alcohol Amnestic Disorder | 0.002367032 | 1 | 0 | GAD |
Amnesia | 0.002367032 | 1 | 0 | GAD |
Fabry Disease | 0.002367032 | 1 | 0 | GAD |
Anoxemia | 0.002367032 | 1 | 0 | GAD |
Aortic Diseases | 0.002367032 | 1 | 0 | GAD |
Asphyxia | 0.002367032 | 1 | 0 | GAD |
Azoospermia | 0.002367032 | 1 | 0 | GAD |
beta Thalassemia | 0.002367032 | 1 | 0 | GAD |
Malignant neoplasm of urinary bladder | 0.002367032 | 1 | 0 | GAD |
Cellulitis | 0.002367032 | 1 | 0 | GAD |
Chorioamnionitis | 0.002367032 | 1 | 0 | GAD |
Chromosome Aberrations | 0.002367032 | 1 | 0 | GAD |
Cognition Disorders | 0.002367032 | 1 | 0 | GAD |
Convalescence | 0.002367032 | 1 | 0 | GAD |
Contact Dermatitis | 0.002367032 | 1 | 0 | GAD |
Edema | 0.002367032 | 1 | 0 | GAD |
Pathological accumulation of air in tissues | 0.002367032 | 1 | 0 | GAD |
Endometrial Neoplasms | 0.002367032 | 1 | 0 | GAD |
Escherichia coli Infections | 0.002367032 | 1 | 0 | GAD |
Disorder of eye | 0.002367032 | 1 | 0 | GAD |
Femur Head Necrosis | 0.002367032 | 1 | 0 | GAD |
Fetal Death | 0.002367032 | 1 | 0 | GAD |
Fetal Diseases | 0.002367032 | 1 | 0 | GAD |
Gastrointestinal Diseases | 0.002367032 | 1 | 0 | GAD |
Gastrointestinal Hemorrhage | 0.002367032 | 1 | 0 | GAD |
Gastrointestinal Neoplasms | 0.002367032 | 1 | 0 | GAD |
Glaucoma | 0.002367032 | 1 | 0 | GAD |
Graft-vs-Host Disease | 0.002367032 | 1 | 0 | GAD |
Hemolytic-Uremic Syndrome | 0.002367032 | 1 | 0 | GAD |
Hepatorenal Syndrome | 0.002367032 | 1 | 0 | GAD |
Hydrocephalus | 0.002367032 | 1 | 0 | GAD |
Hydronephrosis | 0.002367032 | 1 | 0 | GAD |
Hyperparathyroidism, Secondary | 0.002367032 | 1 | 0 | GAD |
Hyperplasia | 0.002367032 | 1 | 0 | GAD |
Immediate hypersensitivity | 0.002367032 | 1 | 0 | GAD |
Intermittent Claudication | 0.002367032 | 1 | 0 | GAD |
Arthropathy | 0.002367032 | 1 | 0 | GAD |
Hyperlipoproteinemia Type I | 0.002367032 | 1 | 0 | GAD |
Low Back Pain | 0.002367032 | 1 | 0 | GAD |
Lymphatic Metastasis | 0.002367032 | 1 | 0 | GAD |
Marfan Syndrome | 0.002367032 | 1 | 0 | GAD |
Meconium Aspiration Syndrome | 0.002367032 | 1 | 0 | GAD |
Mitral Valve Insufficiency | 0.002367032 | 1 | 0 | GAD |
Myasthenia Gravis | 0.002367032 | 1 | 0 | GAD |
Nephritis, Interstitial | 0.002367032 | 1 | 0 | GAD |
Neutropenia | 0.002367032 | 1 | 0 | GAD |
Ocular Hypertension | 0.002367032 | 1 | 0 | GAD |
Disorder of the optic nerve | 0.002367032 | 1 | 0 | GAD |
Bone necrosis | 0.002367032 | 1 | 0 | GAD |
Otosclerosis | 0.002367032 | 1 | 0 | GAD |
Pain, Postoperative | 0.002367032 | 1 | 0 | GAD |
Pancreatic Diseases | 0.002367032 | 1 | 0 | GAD |
Pancreatic Pseudocyst | 0.002367032 | 1 | 0 | GAD |
Peptic Ulcer Hemorrhage | 0.002367032 | 1 | 0 | GAD |
Adenomatous Polyposis Coli | 0.002367032 | 1 | 0 | GAD |
Precancerous Conditions | 0.002367032 | 1 | 0 | GAD |
Puerperal Disorders | 0.002367032 | 1 | 0 | GAD |
Pyelonephritis | 0.002367032 | 1 | 0 | GAD |
Reflex Sympathetic Dystrophy | 0.002367032 | 1 | 0 | GAD |
Renal Artery Obstruction | 0.002367032 | 1 | 0 | GAD |
Respiratory Insufficiency | 0.002367032 | 1 | 0 | GAD |
Retinal vascular occlusion | 0.002367032 | 1 | 0 | GAD |
Rhabdomyolysis | 0.002367032 | 1 | 0 | GAD |
Rhinitis, Allergic, Perennial | 0.002367032 | 1 | 0 | GAD |
Septic Shock | 0.002367032 | 1 | 0 | GAD |
Skin Diseases, Genetic | 0.002367032 | 1 | 0 | GAD |
Sleep Deprivation | 0.002367032 | 1 | 0 | GAD |
Snoring | 0.002367032 | 1 | 0 | GAD |
Streptococcal Infections | 0.002367032 | 1 | 0 | GAD |
Chromosomal translocation | 0.002367032 | 1 | 0 | GAD |
Tricuspid Valve Insufficiency | 0.002367032 | 1 | 0 | GAD |
Urinary Incontinence | 0.002367032 | 1 | 0 | GAD |
Ventricular Fibrillation | 0.002367032 | 1 | 0 | GAD |
Tachycardia, Ventricular | 0.002367032 | 1 | 0 | GAD |
Accelerated Idioventricular Rhythm | 0.002367032 | 1 | 0 | GAD |
Congenital musculoskeletal anomalies | 0.002367032 | 1 | 0 | GAD |
Intracranial Hemorrhages | 0.002367032 | 1 | 0 | GAD |
Optic Neuropathy, Ischemic | 0.002367032 | 1 | 0 | GAD |
Lung Diseases, Interstitial | 0.002367032 | 1 | 0 | GAD |
Diabetic Foot | 0.002367032 | 1 | 0 | GAD |
Exfoliation Syndrome | 0.002367032 | 1 | 0 | GAD |
Mental deterioration | 0.002367032 | 1 | 0 | GAD |
Substance-Related Disorders | 0.002367032 | 1 | 0 | GAD |
Hypoxia | 0.002367032 | 1 | 0 | GAD |
Ventricular Dysfunction, Right | 0.002367032 | 1 | 0 | GAD |
Heat Stress Disorders | 0.002367032 | 1 | 0 | GAD |
Persian Gulf Syndrome | 0.002367032 | 1 | 0 | GAD |
Cardiac Death | 0.002367032 | 1 | 0 | GAD |
Atopy | 0.002367032 | 1 | 0 | GAD |
Left ventricular mass | 0.002367032 | 1 | 0 | GAD |
Hepatopulmonary Syndrome | 0.002367032 | 1 | 0 | GAD |
Encounter due to convalescence | 0.002367032 | 1 | 0 | GAD |
Pregnancy loss | 0.002367032 | 1 | 0 | GAD |
Infarction, Middle Cerebral Artery | 0.002367032 | 1 | 0 | GAD |
Intracranial Arterial Diseases | 0.002367032 | 1 | 0 | GAD |
Sleep Disorders | 0.002367032 | 1 | 0 | GAD |
Blood Coagulation Disorders, Inherited | 0.002367032 | 1 | 0 | GAD |
Sarcopenia | 0.002367032 | 1 | 0 | GAD |
Insulin Sensitivity | 0.002367032 | 1 | 0 | GAD |
Nephroangiosclerosis | 0.002367032 | 1 | 0 | GAD |
Creatinine finding | 0.002367032 | 1 | 0 | GAD |
ASPIRIN RESISTANCE | 0.002367032 | 1 | 0 | GAD |
Hyperglycemia, Postprandial | 0.002367032 | 1 | 0 | GAD |
Memory Impairment Adverse Event | 0.002367032 | 1 | 0 | GAD |
Cicatrix | 0.002367032 | 1 | 0 | GAD |
Cerebral white matter lesion | 0.002367032 | 1 | 0 | GAD |
Infection of amniotic sac and membranes, unspecified, unspecified trimester, not applicable or unspecified | 0.002367032 | 1 | 0 | GAD |
Chronic ulcerative colitis | 0.002367032 | 1 | 0 | GAD |
Recurrent pregnancy loss | 0.002367032 | 1 | 0 | GAD |
THROMBOPHILIA DUE TO THROMBIN DEFECT | 0.002367032 | 1 | 0 | GAD |
Hypotension Adverse Event | 0.002367032 | 1 | 0 | GAD |
Aortic Stiffness | 0.002367032 | 1 | 0 | GAD |
Granulomatosis with polyangiitis | 0.002367032 | 1 | 0 | GAD |
Infection | 0.002367032 | 1 | 0 | GAD |
Renal glomerular disease | 0.001900093 | 7 | 0 | BeFree |
High altitude pulmonary edema | 0.001900093 | 7 | 2 | BeFree |
Prostate carcinoma | 0.001900093 | 7 | 0 | BeFree |
Carcinoma of lung | 0.001900093 | 7 | 0 | BeFree |
Cardiovascular Pathology | 0.001900093 | 7 | 0 | BeFree |
Macroangiopathy | 0.001900093 | 7 | 0 | BeFree |
Erythrocytosis | 0.001900093 | 7 | 0 | BeFree |
Mental disorders | 0.001628651 | 6 | 0 | BeFree |
Borderline Personality Disorder | 0.001628651 | 6 | 2 | BeFree |
Fibrosis, Liver | 0.001628651 | 6 | 0 | BeFree |
Alzheimer Disease, Late Onset | 0.001628651 | 6 | 0 | BeFree |
Carcinogenesis | 0.001628651 | 6 | 0 | BeFree |
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 0.001628651 | 6 | 0 | BeFree |
Aneurysm | 0.001357209 | 5 | 1 | BeFree |
Autoimmune Diseases | 0.001357209 | 5 | 0 | BeFree |
Colorectal Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Hodgkin Disease | 0.001357209 | 5 | 0 | BeFree |
Ovarian Diseases | 0.001357209 | 5 | 0 | BeFree |
Secondary malignant neoplasm of lymph node | 0.001357209 | 5 | 0 | BeFree |
Peripheral Arterial Diseases | 0.001357209 | 5 | 0 | BeFree |
Anxiety Disorders | 0.001085767 | 4 | 0 | BeFree |
Huntington Disease | 0.001085767 | 4 | 0 | BeFree |
Panic Disorder | 0.001085767 | 4 | 0 | BeFree |
Respiration Disorders | 0.001085767 | 4 | 0 | BeFree |
Septicemia | 0.001085767 | 4 | 0 | BeFree |
Pancreatitis, Chronic | 0.001085767 | 4 | 0 | BeFree |
Deep Vein Thrombosis | 0.001085767 | 4 | 0 | BeFree |
Diastrophic dysplasia | 0.001085767 | 4 | 0 | BeFree |
Common Migraine | 0.001085767 | 4 | 0 | BeFree |
Proliferative retinopathy | 0.001085767 | 4 | 0 | BeFree |
Steroid-sensitive nephrotic syndrome | 0.001085767 | 4 | 0 | BeFree |
Community acquired pneumonia | 0.001085767 | 4 | 1 | BeFree |
cardiac event | 0.001085767 | 4 | 1 | BeFree |
Alport Syndrome | 0.001085767 | 4 | 0 | BeFree |
PANIC DISORDER 1 | 0.001085767 | 4 | 0 | BeFree |
Stroke, Lacunar | 0.001085767 | 4 | 0 | BeFree |
Acute pancreatitis | 0.000814326 | 3 | 0 | BeFree |
Adenoma | 0.000814326 | 3 | 0 | BeFree |
Arteriovenous fistula | 0.000814326 | 3 | 0 | BeFree |
Experimental Autoimmune Encephalomyelitis | 0.000814326 | 3 | 0 | BeFree |
Headache | 0.000814326 | 3 | 0 | BeFree |
Malignant Hypertension | 0.000814326 | 3 | 0 | BeFree |
Hypertensive crisis | 0.000814326 | 3 | 0 | BeFree |
Degenerative polyarthritis | 0.000814326 | 3 | 1 | BeFree |
Urologic Diseases | 0.000814326 | 3 | 0 | BeFree |
Hypertensive heart disease | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of mouth | 0.000814326 | 3 | 0 | BeFree |
Disease of capillaries | 0.000814326 | 3 | 0 | BeFree |
Aortic Aneurysm, Thoracic | 0.000814326 | 3 | 4 | BeFree |
Glomerulosclerosis (disorder) | 0.000814326 | 3 | 0 | BeFree |
Lip and Oral Cavity Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Chronic schizophrenia | 0.000814326 | 3 | 0 | BeFree |
Fibrosis of pancreas | 0.000814326 | 3 | 0 | BeFree |
Infarction, Lacunar | 0.000814326 | 3 | 0 | BeFree |
Anterior myocardial infarction | 0.000814326 | 3 | 0 | BeFree |
Aortic aneurysm without mention of rupture NOS | 0.000814326 | 3 | 0 | BeFree |
Dissection of aorta | 0.000814326 | 3 | 0 | BeFree |
Steroid-resistant nephrotic syndrome | 0.000814326 | 3 | 0 | BeFree |
Chronic rejection of renal transplant | 0.000814326 | 3 | 0 | BeFree |
Neurogenic hypertension | 0.000814326 | 3 | 0 | BeFree |
genetic hypertension | 0.000814326 | 3 | 0 | BeFree |
Diabetic peripheral neuropathy | 0.000814326 | 3 | 0 | BeFree |
hypertensive nephropathy | 0.000814326 | 3 | 0 | BeFree |
Dry cough | 0.000814326 | 3 | 0 | BeFree |
Mild cognitive disorder | 0.000814326 | 3 | 0 | BeFree |
Left ventricular systolic dysfunction | 0.000814326 | 3 | 1 | BeFree |
Cardiovascular morbidity | 0.000814326 | 3 | 0 | BeFree |
Peripheral arterial occlusive disease | 0.000814326 | 3 | 0 | BeFree |
Benign Prostatic Hyperplasia | 0.000814326 | 3 | 0 | BeFree |
ABLEPHARON-MACROSTOMIA SYNDROME | 0.000814326 | 3 | 0 | BeFree |
Acute Anterior Wall Myocardial Infarction | 0.000814326 | 3 | 0 | BeFree |
Homocysteinemia | 0.000814326 | 3 | 0 | BeFree |
Airway Obstruction | 0.000542884 | 2 | 0 | BeFree |
Antisocial Personality Disorder | 0.000542884 | 2 | 0 | BeFree |
Coronary Aneurysm | 0.000542884 | 2 | 0 | BeFree |
Coronary Artery Vasospasm | 0.000542884 | 2 | 0 | BeFree |
Gastroesophageal reflux disease | 0.000542884 | 2 | 0 | BeFree |
Nodular glomerulosclerosis | 0.000542884 | 2 | 0 | BeFree |
Cardiac Arrest | 0.000542884 | 2 | 0 | BeFree |
Angioedemas, Hereditary | 0.000542884 | 2 | 0 | BeFree |
Hydrocephalus, Normal Pressure | 0.000542884 | 2 | 0 | BeFree |
Hyperinsulinism | 0.000542884 | 2 | 0 | BeFree |
Mitral Valve Stenosis | 0.000542884 | 2 | 0 | BeFree |
Retinal Vein Occlusion | 0.000542884 | 2 | 1 | BeFree |
Uterine Fibroids | 0.000542884 | 2 | 0 | BeFree |
Virus Diseases | 0.000542884 | 2 | 0 | BeFree |
Depressive Symptoms | 0.000542884 | 2 | 0 | BeFree |
Welts | 0.000542884 | 2 | 0 | BeFree |
Diastolic hypertension | 0.000542884 | 2 | 0 | BeFree |
Congenital diaphragmatic hernia | 0.000542884 | 2 | 0 | BeFree |
Pancreatic carcinoma | 0.000542884 | 2 | 0 | BeFree |
Acute mountain sickness | 0.000542884 | 2 | 0 | BeFree |
5,10-Methylenetetrahydrofolate reductase deficiency | 0.000542884 | 2 | 0 | BeFree |
Very Low Birth Weight | 0.000542884 | 2 | 0 | BeFree |
Senile Plaques | 0.000542884 | 2 | 0 | BeFree |
Segmental glomerulosclerosis | 0.000542884 | 2 | 0 | BeFree |
Glaucoma, Primary Open Angle | 0.000542884 | 2 | 0 | BeFree |
Ventricular hypertrophy | 0.000542884 | 2 | 0 | BeFree |
Stable angina | 0.000542884 | 2 | 0 | BeFree |
Lone atrial fibrillation | 0.000542884 | 2 | 0 | BeFree |
High altitude pulmonary hypertension | 0.000542884 | 2 | 0 | BeFree |
Deep vein thrombosis of lower limb | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of pancreas | 0.000542884 | 2 | 0 | BeFree |
Ischemic cardiomyopathy | 0.000542884 | 2 | 0 | BeFree |
Respiratory distress | 0.000542884 | 2 | 0 | BeFree |
Neurodegenerative Disorders | 0.000542884 | 2 | 0 | BeFree |
Fluid overload | 0.000542884 | 2 | 0 | BeFree |
Dissecting aneurysm of the thoracic aorta | 0.000542884 | 2 | 0 | BeFree |
Lewy Body Disease | 0.000542884 | 2 | 0 | BeFree |
Completed Suicide | 0.000542884 | 2 | 0 | BeFree |
Persistent dry cough | 0.000542884 | 2 | 0 | BeFree |
Nosocomial pneumonia | 0.000542884 | 2 | 1 | BeFree |
Respiratory Failure | 0.000542884 | 2 | 0 | BeFree |
First myocardial infarction | 0.000542884 | 2 | 0 | BeFree |
Precursor B-cell lymphoblastic leukemia | 0.000542884 | 2 | 0 | BeFree |
Cirrhosis | 0.000542884 | 2 | 0 | BeFree |
Primary Focal Segmental Glomerulosclerosis | 0.000542884 | 2 | 0 | BeFree |
Severe Sepsis | 0.000542884 | 2 | 0 | BeFree |
CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5 | 0.000542884 | 2 | 0 | BeFree |
Thrombophilia, hereditary | 0.000542884 | 2 | 0 | BeFree |
Three Vessel Coronary Disease | 0.000542884 | 2 | 0 | BeFree |
Allergic disposition | 0.000542884 | 2 | 0 | BeFree |
Insulin resistance syndrome | 0.000542884 | 2 | 0 | BeFree |
Pneumonitis | 0.000542884 | 2 | 1 | BeFree |
Experimental Organism Basal Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Adrenal Gland Hyperfunction | 0.000271442 | 1 | 0 | BeFree |
Agoraphobia | 0.000271442 | 1 | 0 | BeFree |
Alexithymia | 0.000271442 | 1 | 0 | BeFree |
Angina Pectoris, Variant | 0.000271442 | 1 | 0 | BeFree |
Anuria | 0.000271442 | 1 | 0 | BeFree |
aspirin intolerance | 0.000271442 | 1 | 0 | BeFree |
Nonproliferative diabetic retinopathy | 0.000271442 | 1 | 0 | BeFree |
Bacteremia | 0.000271442 | 1 | 0 | BeFree |
Malignant tumor of colon | 0.000271442 | 1 | 0 | BeFree |
Cardiomyopathy, Alcoholic | 0.000271442 | 1 | 0 | BeFree |
Malignant tumor of cervix | 0.000271442 | 1 | 0 | BeFree |
Chagas Cardiomyopathy | 0.000271442 | 1 | 0 | BeFree |
Chest Pain | 0.000271442 | 1 | 0 | BeFree |
Congenital chromosomal disease | 0.000271442 | 1 | 0 | BeFree |
Chronic cough | 0.000271442 | 1 | 0 | BeFree |
Muscular Dystrophy, Duchenne | 0.000271442 | 1 | 0 | BeFree |
Duodenal Ulcer | 0.000271442 | 1 | 0 | BeFree |
Epilepsy, Temporal Lobe | 0.000271442 | 1 | 0 | BeFree |
Fibromyalgia | 0.000271442 | 1 | 0 | BeFree |
Fibrosarcoma | 0.000271442 | 1 | 0 | BeFree |
pathologic fistula | 0.000271442 | 1 | 0 | BeFree |
Gangrene | 0.000271442 | 1 | 0 | BeFree |
Gastritis | 0.000271442 | 1 | 0 | BeFree |
Gingival Diseases | 0.000271442 | 1 | 0 | BeFree |
Glioblastoma | 0.000271442 | 1 | 0 | BeFree |
Membranous glomerulonephritis | 0.000271442 | 1 | 0 | BeFree |
Heart Block | 0.000271442 | 1 | 0 | BeFree |
Hepatitis B | 0.000271442 | 1 | 0 | BeFree |
Hepatitis, Chronic | 0.000271442 | 1 | 0 | BeFree |
Hyperlipoproteinemias | 0.000271442 | 1 | 0 | BeFree |
Hyperthyroidism | 0.000271442 | 1 | 0 | BeFree |
Influenza | 0.000271442 | 1 | 0 | BeFree |
Acute Promyelocytic Leukemia | 0.000271442 | 1 | 0 | BeFree |
Lymphoma, Non-Hodgkin | 0.000271442 | 1 | 0 | BeFree |
Malaria | 0.000271442 | 1 | 0 | BeFree |
melanoma | 0.000271442 | 1 | 0 | BeFree |
Microangiopathy, Diabetic | 0.000271442 | 1 | 0 | BeFree |
Muscle Rigidity | 0.000271442 | 1 | 0 | BeFree |
Hereditary nephritis | 0.000271442 | 1 | 0 | BeFree |
Nephrosclerosis | 0.000271442 | 1 | 0 | BeFree |
nervous system disorder | 0.000271442 | 1 | 0 | BeFree |
Obesity, Morbid | 0.000271442 | 1 | 0 | BeFree |
Overanxious disorder | 0.000271442 | 1 | 0 | BeFree |
Familial Mediterranean Fever | 0.000271442 | 1 | 0 | BeFree |
Periodontal Diseases | 0.000271442 | 1 | 0 | BeFree |
Pleural effusion disorder | 0.000271442 | 1 | 0 | BeFree |
Pterygium | 0.000271442 | 1 | 0 | BeFree |
Respiratory Syncytial Virus Infections | 0.000271442 | 1 | 0 | BeFree |
Retinal Detachment | 0.000271442 | 1 | 0 | BeFree |
Seminoma | 0.000271442 | 1 | 0 | BeFree |
Gastric ulcer | 0.000271442 | 1 | 0 | BeFree |
Post-Traumatic Stress Disorder | 0.000271442 | 1 | 0 | BeFree |
Stress, Psychological | 0.000271442 | 1 | 0 | BeFree |
Tachycardia, Ectopic Junctional | 0.000271442 | 1 | 0 | BeFree |
Takayasu Arteritis | 0.000271442 | 1 | 0 | BeFree |
Tremor | 0.000271442 | 1 | 0 | BeFree |
Chagas Disease | 0.000271442 | 1 | 0 | BeFree |
Turner Syndrome | 0.000271442 | 1 | 0 | BeFree |
Werner Syndrome | 0.000271442 | 1 | 0 | BeFree |
Severe Combined Immunodeficiency | 0.000271442 | 1 | 0 | BeFree |
Seasonal Affective Disorder | 0.000271442 | 1 | 0 | BeFree |
Ovarian Failure, Premature | 0.000271442 | 1 | 0 | BeFree |
Encephalopathies | 0.000271442 | 1 | 0 | BeFree |
Acute leukemia | 0.000271442 | 1 | 0 | BeFree |
Cataract | 0.000271442 | 1 | 0 | BeFree |
Esophageal carcinoma | 0.000271442 | 1 | 0 | BeFree |
Drug withdrawal syndrome | 0.000271442 | 1 | 0 | BeFree |
Recurrent major depressive episodes | 0.000271442 | 1 | 0 | BeFree |
Secondary hypertension | 0.000271442 | 1 | 0 | BeFree |
Atherosclerosis of aorta | 0.000271442 | 1 | 0 | BeFree |
Tumor Progression | 0.000271442 | 1 | 0 | BeFree |
Urinary tract obstruction | 0.000271442 | 1 | 0 | BeFree |
Germ cell tumor | 0.000271442 | 1 | 0 | BeFree |
Pneumonia, Interstitial | 0.000271442 | 1 | 0 | BeFree |
Chronic berylliosis | 0.000271442 | 1 | 0 | BeFree |
Systolic hypertension | 0.000271442 | 1 | 0 | BeFree |
Extrapyramidal sign | 0.000271442 | 1 | 0 | BeFree |
Cerebral atrophy | 0.000271442 | 1 | 0 | BeFree |
Left atrial hypertrophy | 0.000271442 | 1 | 0 | BeFree |
Interstitial fibrosis | 0.000271442 | 1 | 0 | BeFree |
Drug usage | 0.000271442 | 1 | 0 | BeFree |
Borderline hypertension | 0.000271442 | 1 | 0 | BeFree |
Chronic urticaria | 0.000271442 | 1 | 0 | BeFree |
Coronary artery atheroma | 0.000271442 | 1 | 0 | BeFree |
Ventricular dilatation (disorder) | 0.000271442 | 1 | 0 | BeFree |
Unilateral agenesis of kidney | 0.000271442 | 1 | 0 | BeFree |
Renal vascular disorder | 0.000271442 | 1 | 0 | BeFree |
Liver and Intrahepatic Biliary Tract Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Infant, Very Low Birth Weight | 0.000271442 | 1 | 0 | BeFree |
Cervix carcinoma | 0.000271442 | 1 | 0 | BeFree |
Silent myocardial ischemia | 0.000271442 | 1 | 0 | BeFree |
Arteriovenous fistula thrombosis | 0.000271442 | 1 | 0 | BeFree |
Chronic liver disease | 0.000271442 | 1 | 0 | BeFree |
Generalized glycogen storage disease of infants | 0.000271442 | 1 | 0 | BeFree |
Atrioventricular septal defect and common atrioventricular junction | 0.000271442 | 1 | 0 | BeFree |
Left ventricular dilatation | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of liver | 0.000271442 | 1 | 0 | BeFree |
Dysgerminoma of ovary | 0.000271442 | 1 | 0 | BeFree |
Early gastric cancer | 0.000271442 | 1 | 0 | BeFree |
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site | 0.000271442 | 1 | 0 | BeFree |
Primary vesicoureteric reflux | 0.000271442 | 1 | 0 | BeFree |
Chronic small plaque psoriasis | 0.000271442 | 1 | 0 | BeFree |
Impaired exercise tolerance | 0.000271442 | 1 | 0 | BeFree |
Aortic valve calcification | 0.000271442 | 1 | 0 | BeFree |
Nephrotic range proteinuria | 0.000271442 | 1 | 0 | BeFree |
Complex Regional Pain Syndromes | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of liver | 0.000271442 | 1 | 0 | BeFree |
Necrotizing Enterocolitis | 0.000271442 | 1 | 0 | BeFree |
Acute pyelonephritis | 0.000271442 | 1 | 0 | BeFree |
Granulomatosis | 0.000271442 | 1 | 0 | BeFree |
Bilateral cataracts (disorder) | 0.000271442 | 1 | 0 | BeFree |
Symptoms of stress | 0.000271442 | 1 | 0 | BeFree |
Activated Protein C Resistance | 0.000271442 | 1 | 0 | BeFree |
Progressive Neoplastic Disease | 0.000271442 | 1 | 0 | BeFree |
Nephronophthisis | 0.000271442 | 1 | 0 | BeFree |
Colon Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of kidney | 0.000271442 | 1 | 0 | BeFree |
Cardiac defects | 0.000271442 | 1 | 0 | BeFree |
Lymphangioleiomyomatosis | 0.000271442 | 1 | 0 | BeFree |
Schizophrenia and related disorders | 0.000271442 | 1 | 0 | BeFree |
Invasive breast carcinoma | 0.000271442 | 1 | 0 | BeFree |
Cognitive deterioration | 0.000271442 | 1 | 0 | BeFree |
Post MI | 0.000271442 | 1 | 0 | BeFree |
Advanced cancer | 0.000271442 | 1 | 0 | BeFree |
Vascular inflammations | 0.000271442 | 1 | 0 | BeFree |
Chronic systolic heart failure | 0.000271442 | 1 | 0 | BeFree |
Drusen | 0.000271442 | 1 | 0 | BeFree |
Renal carcinoma | 0.000271442 | 1 | 0 | BeFree |
ATRIOVENTRICULAR CANAL DEFECT | 0.000271442 | 1 | 0 | BeFree |
Atrioventricular Septal Defect | 0.000271442 | 1 | 0 | BeFree |
Cognitive changes | 0.000271442 | 1 | 0 | BeFree |
Cardiac fibrosis | 0.000271442 | 1 | 0 | BeFree |
Tumor Angiogenesis | 0.000271442 | 1 | 0 | BeFree |
Overweight and obesity | 0.000271442 | 1 | 0 | BeFree |
Chronic uremia | 0.000271442 | 1 | 0 | BeFree |
Hyperlipoproteinemia Type IIb | 0.000271442 | 1 | 0 | BeFree |
Non-Neoplastic Disorder | 0.000271442 | 1 | 0 | BeFree |
AURAL ATRESIA, CONGENITAL | 0.000271442 | 1 | 0 | BeFree |
BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE | 0.000271442 | 1 | 0 | BeFree |
Nephronophthisis, familial juvenile | 0.000271442 | 1 | 0 | BeFree |
OVERLAP CONNECTIVE TISSUE DISEASE | 0.000271442 | 1 | 0 | BeFree |
THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE (disorder) | 0.000271442 | 1 | 0 | BeFree |
Transformed migraine | 0.000271442 | 1 | 0 | BeFree |
Cakut | 0.000271442 | 1 | 0 | BeFree |
Left Main Coronary Artery Stenosis | 0.000271442 | 1 | 0 | BeFree |
Beryllium Disease | 0.000271442 | 1 | 0 | BeFree |
Chronic thromboembolic pulmonary hypertension | 0.000271442 | 1 | 0 | BeFree |
Cerebral Small Vessel Diseases | 0.000271442 | 1 | 0 | BeFree |
Promyelocytic leukemia | 0.000271442 | 1 | 0 | BeFree |
Low density lipoprotein receptor mutation | 0.000271442 | 1 | 0 | BeFree |
Amyloid angiopathy | 0.000271442 | 1 | 0 | BeFree |
Primary immunoglobulin A nephropathy (disorder) | 0.000271442 | 1 | 0 | BeFree |
Nonalcoholic Steatohepatitis | 0.000271442 | 1 | 0 | BeFree |
Progressive cGVHD | 0.000271442 | 1 | 0 | BeFree |
AORTIC VALVE DISEASE 2 | 0.000271442 | 1 | 0 | BeFree |
Renal Artery Disease | 0.000271442 | 1 | 0 | BeFree |
Dementia due to Alzheimer's disease (disorder) | 0.000271442 | 1 | 0 | BeFree |
Juvenile rheumatoid arthritis | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。